Matsubara et al described histopathologic changes seen in nasal biopsies from patients with early Wegener's granulomatosis. The authors are from the National Defense Medical College in Saitama, Japan, Tokyo Medical and Dental University, and Massachusetts General Hospital.
Definitions of key inflammatory lesions:
(1) Palisading granuloma = an aggregate of histiocytes with parallel nuclei radiating around a necrotic nidus with neutrophils and nuclear dust; a granuloma < 1 mm in diameter is called a microgranuloma; a granuloma >= 1 mm in diameter is called a mcrogranuloma
(2) Diffuse granulomatous tissue = sheets of epithelioid histiocytes and multinucleated giant cells mixed with eosinophils, lymphocytes and plasma cells
(3) Leukocytoclastic capillaritis = fibrinoid necrosis, neutrophils and nuclear dust in the wall of a capillary
(4) Leukocytoclastic endovasculitis = fibrinoid necrosis, neutrophils and nuclear dust limited to the intima of a blood vessel (transmural inflammation absent)
Vascular lesions:
(1) microabscesses
(2) leukocytoclastic vasculitis
(3) leukocytoclastic capillaritis
(4) leukocytoclastic endovasculitis
(5) fibrinoid necrosis
(6) palisading granulomas
(7) fresh or organized thrombosis
Nonvascular lesions:
(1) palisading granulomas
(2) microabscesses
(3) diffuse granulomatous tissue
(4) neutrophilic infiltration of nasal glands
Key histologic features for making the diagnosis of Wegener's granulomatosis:
(1) vascular or nonvascular palisading granulomas
(2) microabscesses in vessel walls
(3) leukocytoclastic vasculitis
Signs of poor prognosis:
(1) leukocytoclastic vasculitis
(2) leukocytoclastic endovasculitis (seen only in fatal cases)
Purpose: Ti evaluate a nasal biopsy for histologic evidence of Wegener's granulomatosis using the criteria of Matsubara et al.
Specialty: Immunology/Rheumatology
Objective: other testing, criteria for diagnosis
ICD-10: M31.3,